GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (BOM:500674) » Definitions » Price-to-Funds-From-Operations

Sanofi India (BOM:500674) Price-to-Funds-From-Operations : (As of Jun. 25, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Sanofi India Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Sanofi India (BOM:500674) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.